☕️ Innovation Espresso #3
☕️ Innovation Espresso #3
Google turns to nuclear, Worldcoin’s latest orb tech, and breakthroughs in biotech, plus your weekly shot of corporate venturing news.
Welcome to Innovation Espresso, a quick yet powerful dose of curated news, articles, videos, reels, newsletters, and podcasts that I’ve found particularly interesting throughout the week. While we focus on Open Innovation and Corporate Venturing, you’ll find this quick yet potent dose covers more ground. Enjoy with your morning coffee!
💊 Innovation Pills
• €1bn US battery plant plan ups ante in race to reduce reliance on China
• People are falling in love with — and getting addicted to — AI voices
• Sam Altman’s Worldcoin becomes World, showing new iris-scanning orb to prove humanity
• AI domain names are the next big thing on the internet, and it’s great news for Anguilla
• Lucid dreams might help people communicate in new ways
• SpaceX catches giant Starship booster with 'Chopsticks'
• Google turns to nuclear to power AI data centres
☕️ Your weekly sip of Corporate Venturing News
• L’Oréal and Evonik back Abolis’ Series A funding: Synthetic biology startup Abolis raised Series A funding, with L’Oréal and Evonik as key investors, focusing on bio-based materials for cosmetics and chemicals. Source
• Big Pharma’s European startup funding spree: Big pharmaceutical firms are stepping in to support innovation in healthcare through strategic investments. Source
• Gartner’s comparison of generative AI use cases in IT: Gartner compares how IT organizations are deploying generative AI for task automation and decision-making. Source
• Smaller corporates embrace venture building: Increasingly, smaller companies are adopting venture building as a method to drive internal innovation. Source
• Scope3 raises $25M to decarbonize digital media: Scope3 secures funding to reduce emissions across digital supply chains. Source
• Onlygood.ai raises funds for ESG stack: Onlygood.ai enhances its ESG stack with funding from Daimler India and IIT Madras. Source
• Arda Therapeutics secures $43M for targeted cell depletion therapies: Arda Therapeutics advances its innovative cell depletion therapies with new funding. Source
📹 Something to watch
This reel really cracked me up! And it reminded me this Medium post.
🎧 Something to listen
In this episode of WSJ’s The Future of Everything, reporters discuss the booming longevity business, where innovations in health and wellness aim to extend our lifespan. But is there a limit to how long we can live? Scientists debate whether we’ve hit a natural ceiling despite increased life expectancy.
🛠️ Something to try
If you’re looking for an AI-powered search tool with concise, quick answers to your queries, Perplexity is a great one to explore. It’s like having an AI assistant to help you navigate the web and find information rapidly. Try Perplexity.
🥐 Espresso is not enough?
Curious about how the next generation of managers is leveraging generative AI? This article from Harvard Business Review explores how Gen AI is reshaping management practices, from decision-making to task automation, and what this means for the future of leadership. Read the full article here.
Did you enjoy this edition? Share it with anyone you like and give it a heart. Subscribe to receive it every week.
See you next week,
Davide